TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Cellino has launched Reservoir, a service that collects and cryopreserves adults’ immune cells for potential future medical use. It typically costs about $5,000 for collection, processing and the first storage year, followed by $270 annually; the medical value of banking cells for healthy adults remains uncertain.
Biotech company Cellino has launched Reservoir, a consumer service that collects and cryopreserves adults’ immune cells for possible future medical use. The service typically starts at about $5,000, including collection, processing and the first year of storage, then costs $270 annually; whether the stored cells will benefit healthy customers in future treatments is not established.
Reservoir collects cells through a standard blood draw at a partner clinic or, in select locations, an at-home appointment. Cellino says it isolates peripheral blood mononuclear cells, or PBMCs, which include T cells, B cells, natural killer cells and monocytes. The cells are counted, frozen and stored below -150°C at an FDA-registered facility, with tracking documented through the process.
Cellino says customers retain ownership of their samples, which are released only at the customer’s request and in coordination with a licensed physician. Pricing varies by clinic but typically begins around $5,000 and covers collection, processing, cryopreservation and the first storage year. The company lists an ongoing $270 annual storage fee after that.
The service is open to adults 18 and older and is initially offered through partner clinics in San Francisco, Los Angeles, New York and Boston. At-home collection is available in select markets, and Cellino says it plans to add locations. Consumers can check availability or join a nationwide waitlist through Reservoir’s website.
A Bet on Future Cell Therapies
Reservoir brings cell preservation directly to consumers who want to retain biological material before aging changes their immune-cell populations. Cellino is selling the service as a way to preserve future options, not as a treatment or a demonstrated way to extend life. That distinction matters: customers pay a substantial upfront cost and annual storage fees without a defined medical use or guarantee that future therapies will be able to use their samples.
The launch also extends Cellino’s work beyond technology for manufacturing personalized cell therapies into a consumer health service. Its commercial case depends partly on whether later medical advances create useful applications for stored cells. For now, the company is offering preservation, while the potential clinical payoff remains uncertain.
As an affiliate, we earn on qualifying purchases.
Cellino’s Shift to Consumer Banking
Cellino, based in Cambridge, Massachusetts, was co-founded in 2017 by Nabiha Saklayen and Marinna Madrid after research at Harvard. The company develops automated manufacturing technology intended to support production of personalized cell therapies. The original report says Cellino has raised more than $96 million from investors including Khosla Ventures, 8VC, Felicis and Leaps by Bayer, and received an award of up to $25 million from ARPA-H.
Chief executive Saklayen told Athletech News that people who heard about the company’s work repeatedly asked whether they could preserve their own cells. She said some families and individuals were already doing so, but access was difficult and services were not designed for consumers. Reservoir adapts cryopreservation—already used in research and medical settings—into a direct-to-consumer offering. Its comparison with egg freezing and cord-blood banking describes the service model, not proof that the stored immune cells will have established future uses.
“Cell preservation is unique because it is fundamentally about optionality: preserving your cells as they are today, so that whatever the science makes possible later, you still have the material to use.”
— Jay Luthar, Harvard Medical School faculty member and founder of partner clinic Lutanen Health
personal immune cell storage service
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Future Uses Remain Unproven
The central unknown is whether a customer’s stored immune cells will be usable or beneficial in any future treatment. The report does not identify an approved therapy or a clinical indication for which Reservoir samples are currently intended. It also does not provide evidence that banking immune cells improves longevity or health outcomes for otherwise healthy adults.
Cellino says samples are held at an FDA-registered facility, but the report does not detail the facility’s name, storage duration, procedures if the company or storage provider stops operating, or whether additional costs would apply to retrieve and prepare cells. Pricing can vary by clinic, and the stated annual fee does not answer every question about long-term costs. These details remain important for prospective customers to clarify directly with the company.
As an affiliate, we earn on qualifying purchases.
Expansion and Customer Access
Cellino says it plans to add markets beyond the initial partner-clinic locations and is accepting names for a nationwide waitlist. Availability for at-home collection will depend on location. The company has not announced a timeline for broader access or identified a next clinical milestone tied to Reservoir’s stored samples.
As the service rolls out, prospective customers can check local availability and ask Cellino and participating clinics about storage terms, sample release, ongoing fees and the process for physician coordination. Whether future research or therapies give stored cells a defined medical role remains an open question.
As an affiliate, we earn on qualifying purchases.
Key Questions
What does Cellino’s Reservoir service do?
Reservoir collects a blood sample, isolates peripheral blood mononuclear cells, then cryopreserves and stores them for possible future medical use. Cellino says the sample is tracked and released at the customer’s request in coordination with a licensed physician.
How much does immune cell banking cost?
The service typically starts at about $5,000, covering collection, processing, freezing and the first year of storage. Cellino lists an additional $270 annual fee after the first year, with prices varying by clinic.
Can stored immune cells treat disease or extend life?
The source report does not identify an established treatment or longevity benefit from banking immune cells for healthy adults. Cellino presents Reservoir as preserving cells for potential future use, and the usefulness of that option remains uncertain.
Where is Reservoir available?
The initial partner-clinic markets include San Francisco, Los Angeles, New York and Boston. At-home collection is offered in select locations, and Cellino says additional markets are planned.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
